Articles About Forest Laboratories
-
May 02, 20133 Healthcare Stock Stories For Midweek Wellness
Here are some top Healthcare stock stories for the afternoon: 3 Healthcare Stock Stories For Midweek Wellness
-
April 12, 2013Home Depot Opposes Plastic Settlement and 2 Stocks at 52-Week Highs
See how many top stocks hit 52-week highs Thursday...
-
January 16, 2013Forest Laboratories Earnings Call Insights: Rebate Charges and Product Sales Trends
What investors need to know...
-
January 15, 2013Is Forest Laboratories a Buy Now?
It’s obvious that investors aren’t sure what to make of the situation...
-
January 15, 2013Forest Labs Earnings: Here’s Why Investors Are Booking Profits
Take a closer look now...
-
October 17, 2012
Forest Laboratories Earnings Call Nuggets: Individual Product Guidance, Linzess Launch
What investors need to know...
-
September 27, 2012Healthcare Business Roundup: Depomed Sues the FDA, Abbott Gets Orphan Designation In EU
Your Cheat Sheet to the top healthcare business news...
-
August 10, 2012
Healthcare Biz Recap: Carl Icahn TRASHES Forest Labs, Perrigo WINS FDA Okay
Your Cheat Sheet to the top healthcare business news...
-
August 01, 2012
Healthcare Business Rewind: Pharmacyclics Rakes In MILESTONES, Dendreon In TROUBLE
Your Cheat Sheet to the top healthcare business news...
-
July 18, 2012
Forest Labs Earnings Call INSIGHTS: Effective Tax Rate, Trial Talk
What investors need to know...
-
June 29, 2012
Healthcare Biz Review: Icahn SUES Forest, eHealth’s EXCELLENT News
Your Cheat Sheet to the top healthcare business news ...
-
June 20, 2012
Healthcare Biz Recap: Forest Laboratories Icahn ATTACK, Supreme Court JITTERS
Your Cheat Sheet to the top healthcare business news ...
-
June 11, 2012Mid-Day Lowdown: Apple Wobbles With Anxiety, Facebook Growth WANES
Analysis on highly active stocks for investors...
-
May 31, 2012Wall St. Brief: Oracle and H-P Court Battle, JPMorgan Details Emerge
Today's top stories swirling around Wall Street and moving markets ...
-
April 19, 2012
Johnson & Johnson Barters for EU Approval of Synthes Deal
Johnson & Johnson has agreed to sell its orthopaedics business to relieve antitrust concerns in the EU over its $21.3 billion purchase of Synthes Inc...
Wall St. Cheat Sheet has been featured in these fine media outlets:
